Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Dull

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The American Journal of Tropical Medicine and Hygiene|June 24, 2004
The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, NepalDavid R Murdoch, Christopher W Woods, Mark D Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During PregnancyShabir A Madhi, Anthonet Koen, Clare L Cutland, et al.
The Lancet. Infectious Diseases|February 13, 2016
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trialRobert S Heyderman, Shabir A Madhi, Neil French, et al.
The Lancet. Infectious Diseases|May 4, 2016
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trialShabir A Madhi, Clare L Cutland, Lisa Jose, et al.
JAMA|April 29, 2004
One-year health assessment of adult survivors of Bacillus anthracis infectionDori B Reissman, Ellen A S Whitney, Thomas H Taylor, et al.
Emerging Infectious Diseases|October 25, 2002
Bacillus anthracis aerosolization associated with a contaminated mail sorting machinePeter M Dull, Kathy E Wilson, Bill Kournikakis, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
The Pediatric Infectious Disease Journal|January 13, 2016
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of AgeMatthew D Snape, Merryn Voysey, Adam Finn, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infantsKirsten P Perrett, Matthew D Snape, Karen J Ford, et al.
Vaccine|January 9, 2014
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infantsArturo Abdelnour, Peter E Silas, Marta Raquel Valdés Lamas, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The American Journal of Tropical Medicine and Hygiene|June 24, 2004
The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, NepalDavid R Murdoch, Christopher W Woods, Mark D Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During PregnancyShabir A Madhi, Anthonet Koen, Clare L Cutland, et al.
The Lancet. Infectious Diseases|February 13, 2016
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trialRobert S Heyderman, Shabir A Madhi, Neil French, et al.
The Lancet. Infectious Diseases|May 4, 2016
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trialShabir A Madhi, Clare L Cutland, Lisa Jose, et al.
JAMA|April 29, 2004
One-year health assessment of adult survivors of Bacillus anthracis infectionDori B Reissman, Ellen A S Whitney, Thomas H Taylor, et al.
Emerging Infectious Diseases|October 25, 2002
Bacillus anthracis aerosolization associated with a contaminated mail sorting machinePeter M Dull, Kathy E Wilson, Bill Kournikakis, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
The Pediatric Infectious Disease Journal|January 13, 2016
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of AgeMatthew D Snape, Merryn Voysey, Adam Finn, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infantsKirsten P Perrett, Matthew D Snape, Karen J Ford, et al.
Vaccine|January 9, 2014
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infantsArturo Abdelnour, Peter E Silas, Marta Raquel Valdés Lamas, et al.
Pageof 5